Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,877,065
in 6 filings, $10.0M under 10b5-1 plans

Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-09 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +7,136 7,136
2023-06-09 Bitterman Kevin Director Grant or award · Stock Option (Right to Buy) +7,136 7,136
2023-06-09 White William Richard Director Grant or award · Stock Option (Right to Buy) +7,136 7,136
2023-06-09 Ashiya Mona Director Grant or award · Stock Option (Right to Buy) +7,136 7,136
2023-02-15 AI DMI LLC 10% owner Purchase +434,783 $23.00 $10.0M 3,141,759
2023-02-15 Ashiya Mona Director Purchase +57,318 $23.00 $1.3M 1,196,825
2023-02-15 Ashiya Mona Director Purchase +37,049 $23.00 $852K 773,607
2023-02-15 Ashiya Mona Director Purchase +14,329 $23.00 $330K 299,205
2023-02-15 ORBIMED ADVISORS LLC Director Purchase +57,318 $23.00 $1.3M 1,196,825
2023-02-15 ORBIMED ADVISORS LLC Director Purchase +37,049 $23.00 $852K 773,607
2023-02-15 ORBIMED ADVISORS LLC Director Purchase +14,329 $23.00 $330K 299,205
2022-12-29 Atlas Venture Fund X, L.P. 10% owner Other acquisition +1,835,799 2,237,303
2022-12-29 Atlas Venture Fund X, L.P. 10% owner Other acquisition +882,224 955,156
2022-12-29 ORBIMED ADVISORS LLC Director Other acquisition +284,876 284,876
2022-12-29 ORBIMED ADVISORS LLC Director Other acquisition +582,622 582,622
2022-12-29 ORBIMED ADVISORS LLC Director Other acquisition +153,936 736,558
2022-12-29 ORBIMED ADVISORS LLC Director Other acquisition +1,139,507 1,139,507
2022-12-29 Bitterman Kevin Director Grant or award · Stock Option (Right to Buy) +7,000 7,000
2022-12-29 Ashiya Mona Director Grant or award · Stock Option (Right to Buy) +7,000 7,000
2022-12-29 Nicholson Donald William Director Grant or award · Stock Option (Right to Buy) +7,000 7,000

Page 31 of 32 · 639 trades